Where does Equashield Medical Ltd rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Equashield Medical Ltd ranks #9,028 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Equashield Medical Ltd hold?

Equashield Medical Ltd holds 35 US utility patents granted between 2016 and 2025, spanning 16 technology areas.

What is Equashield Medical Ltd's Innovation Score?

Equashield Medical Ltd has an Innovation Score of 55.5 out of 100 (top 7% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

Is Equashield Medical Ltd's patent grant rate increasing or decreasing?

Equashield Medical Ltd's recent grant velocity is +200% compared to the prior five-year period (grant years, not application filing dates). This indicates accelerating grant output.

What does claim depth mean for Equashield Medical Ltd's patents?

Equashield Medical Ltd's patents average 14.9 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Equashield Medical Ltd patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView Foreign Corporation

Equashield Medical Ltd

Q: What technology areas does Equashield Medical Ltd focus on?

Equashield Medical Ltd's top technology area is A61J (Containers Specially Adapted FOR Medical OR Pharmaceutical PURPOSES; Devices OR Methods Specially Adapted FOR Bringing Pharmaceutical Products Into Particular Physical OR Administering FORMS; Devices FOR Administering Food OR Medicines ORALLY; Baby COMFORTERS; Devices FOR Receiving Spittle) with 27 patents, ranking #22 of 903 assignees active in that subclass. Grants appear in 16 CPC subclasses total.

USPTO PatentsView assignee record - 35 granted patents across 16 technology areas, recorded in grant years 2016–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61J (Containers Specially Adapted FOR Medical OR Pharmaceutical PURPOSES; Devices OR Methods Specially Adapted FOR Bringing Pharmaceutical Products Into Particular Physical OR Administering FORMS; Devices ).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Equashield ranks #9,028 of 49,997 tracked US assignees by granted-patent volume, with 35 patents across 16 technology areas.

#9,028
of 49,997 US assignees by volume: Top 7%
by Innovation Score (55.5/100): 14.9
avg claims per patent: +200%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R9028 · Foreign Corporation #9,028 · 35 grants

GRANTS-SMALL · UPPER-Q · PHOTO-FINISH · CPC-FOCUS · INNOV-PAR · CLAIMS-RICH · TYPE-FRNCORP · VEL-SURGE · BOOK-FULL

GRANTS-SMALL 35 grants
UPPER-Q #9,028/49,997
PHOTO-FINISH Dart Container
CPC-FOCUS A61J · 16 areas
INNOV-PAR 55.5/100
CLAIMS-RICH 14.9 claims/avg
TYPE-FRNCORP Foreign Corp
VEL-SURGE +200% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Dart Container Corporation (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Equashield’s 55.5 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 12.4 pts (22%) Velocity 20.0 pts (36%) Breadth 14.1 pts (25%) Claim depth 9.0 pts (16%)

Qualcomm Incorporated · highest

85
Joulwatt Technology · near

56
Recursion Pharmaceut… · near

56
Equashield Medical · this assignee

55
Nokomis · near

55
NthDegree Worldwide · near

55
3D Lighting… · lowest

7

What this shows Equashield's Innovation Score is 55.5/100 (top 7% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Equashield?

Each dot is one of Equashield’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Equashield’s own 14.9 claims/patent is at or below the 15.8 median for these volume peers. Volume here does not track with deeper claims; several lower-volume peers claim more thoroughly per patent.

Equashield vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Equashield's grants concentrate

Equashield Medical Ltd is a focused PatentsView assignee: 16 CPC subclasses with 77.1% of grants classified under A61J (Containers Specially Adapted FOR Medical OR Pharmaceutical PURPOSES; Devices OR Methods Specially Adapted FOR Bringing Pharmaceutical Products Into Particular Physical OR Administering FORMS; Devices ). Peak complete grant year is 2024 (14 grants) versus a trough of 1 in 2016. By volume, Equashield sits between Dart Container Corporation and Elliptic Laboratories ASA.

Equashield's three-year grant acceleration

Equashield Medical Ltd shows 18 grants in 2022–2024 against only 6 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Dart Container

35
Doosan Bobcat Nor…

35
EBR Systems

35
Epiroc Rock Drill…

35
Eutelsat

35
Ecole Normale Sup…

35
Electrolux do Bra…

35
Elliptic Laborato…

35
Equashield Medical ◀

35

What this shows Equashield holds 35 patents at rank #9,023, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Equashield

By rank, the assignees closest to #9,023 in granted patent volume.

Leaders in A61J (Containers Specially Adapted FOR Medical OR Pharmaceutica…)

Other assignees with the most granted patents in Equashield's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for Equashield, neither rank-band nor same-CPC leaders (those blocks stay above). In A61J (Containers Specially Adapted FOR Medical OR Pharmaceutica…), Equashield ranks #22 of 903 assignees by patent count in that subclass.

Similar innovation score

Nearest assignees by Innovation Score (55 here).

Nokomis, Inc. 55 NthDegree Technologies Worldwide Inc 55 Joulwatt Technology Co., Ltd. 56 Recursion Pharmaceuticals, Inc. 56

Equashield's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

55 Top 7% higher than 93% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2016–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2016–2019 baseline. Full figures in the table below.

View data table

Equashield Medical Ltd patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2016	1	2.9%
2017	1	2.9%
2018	2	5.7%
2019	3	8.6%
2020	1	2.9%
2021	2	5.7%
2022	1	2.9%
2023	3	8.6%
2024	14	40.0%
2025partial year	7	20.0%

Which technologies does Equashield Medical Ltd patent most?

A61J - Containers Specially Adapted FOR Medical OR Pharmaceutical PURPOSES; Devices OR Methods Specially Adapted FOR Bringing Pharmaceutical Products Into Particular Physical OR Administering FORMS; Devices FOR Administering Food OR Medicines ORALLY; Baby COMFORTERS; Devices FOR Receiving Spittle 27

B65B - Machines, Apparatus OR Devices FOR, OR Methods OF, Packaging Articles OR MATERIALS; Unpacking 14

A61M - Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor 10

B25J - MANIPULATORS; Chambers Provided With Manipulation Devices 8

G05D - Systems FOR Controlling OR Regulating Non-electric Variables 3

G06V - Image OR Video Recognition OR Understanding 2

G06F - Electric Digital Data Processing 2

G07F - Coin-freed OR Like Apparatus 2

G06Q - Information AND Communication Technology [ICT] Specially Adapted FOR Administrative, Commercial, Financial, Managerial OR Supervisory PURPOSES; Systems OR Methods Specially Adapted FOR Administrative, Commercial, Financial, Managerial OR Supervisory Purposes, NOT Otherwise Provided FOR 2

G01F - Measuring Volume, Volume Flow, Mass Flow OR Liquid LEVEL; Metering BY Volume 2

G08B - Signalling OR Calling SYSTEMS; Order TELEGRAPHS; Alarm Systems 2

H04N - Pictorial Communication, e.g. Television 2

G16Z - Information AND Communication Technology [ICT] Specially Adapted FOR Specific Application Fields, NOT Otherwise Provided FOR 2

G06T - Image Data Processing OR Generation, IN General 2

G16H - Healthcare Informatics, i.e. Information AND Communication Technology [ICT] Specially Adapted FOR THE Handling OR Processing OF Medical OR Healthcare Data 2

Top 15 of 16 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Equashield Medical Ltd's patent record in context - here's where to go next.

Equashield Medical Ltd's lead technology class is A61J (Containers Specially Adapted FOR Medical OR Pharmaceutical PURPOSES; Devices OR Methods Specially Adapted FOR Bringing Pharmaceutical Products Into Particular Physical OR Administering FORMS; Devices ), 77.1% of its portfolio - see every assignee active in that class. Explore A61J
Ranked #9,028 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Equashield Medical Ltd against Dart Container Corporation, an assignee filing at a similar volume. Compare portfolios
Innovation Score of 55.5/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.